Citizens JMP Downgrades Iovanace Biotherapeutics (IOVA) to Market Perform

May 9, 2025 3:41 AM EDT Send to a Friend
Citizens JMP analyst Reni J. Benjamin downgraded Iovanace Biotherapeutics ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login